APCCC 2024: Future Changes in the Setting of mHSPC
APCCC 2024 management of mHSPC, future changes in the setting of mHSPC, role for immune checkpoint inhibition in unselected M1 prostate cancer among men starting ADT, CAPItello-281, AMPLITUDE, TALAPRO-3, PSMAddition, CYCLONE-03.